Buprenorphine use in pregnant opioid users: a critical review.

about

Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.Pharmacological Management of Opioid Use Disorder in Pregnant Women.A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.

P2860

Q38244651-6EB7DB02-BFFA-4F58-8C77-BF71F4847529 Q38575591-2B35F2FC-ED27-4B6B-8EE3-9DA36CBB16DC Q44344923-72722570-F255-47CC-8817-60B6D51318B9

P2860

Buprenorphine use in pregnant opioid users: a critical review.

Item

http://www.wikidata.org/entity/Q38115201

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Buprenorphine use in pregnant opioid users: a critical review.

@en

type

Item

label

Buprenorphine use in pregnant opioid users: a critical review.

@en

prefLabel

Buprenorphine use in pregnant opioid users: a critical review.

@en

P1476

Buprenorphine use in pregnant opioid users: a critical review.

@en

P2093

Michael Soyka

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance agonist treatments for opiate dependent pregnant women

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain

Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit

The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Neonatal abstinence syndrome after methadone or buprenorphine exposure

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.

Substance use in pregnancy.

P2888

s40263-013-0072-z

P304

653-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-013-0072-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239942777

http://www.w3.org/2001/XMLSchema#string

P698

23775478

http://www.w3.org/2001/XMLSchema#string

Buprenorphine use in pregnant opioid users: a critical review.

about

P2860

P2860

Buprenorphine use in pregnant opioid users: a critical review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698